This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Major vertical integration continues with Cigna's $67bn buy of PBM Express Scripts
19 Sep 2018
In the second major vertical integration within the last several months, Cigna Corp. acquired pharmacy benefit manager (PBM) Express Scripts Holding Co. for $67bn. Each Express Scripts share will be exchanged for $48.25 in cash and 0.2434 in the combined company's stock, for a total per-share value of $96.02 (based on the ten-day stock averages of both companies; a 27% premium). Cigna is also assuming $15bn in Express Scripts debt ($13bn net debt). The new entity, to be called Cigna, will be owned 64% by Cigna shareholders, and the rest Express Scripts.
Payment Includes Cash
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?